Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Bossis

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Cancers|October 10, 2020
DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic TargetsLudovic Gabellier, Caroline Bret, Guillaume Bossis, et al.
Molecules (Basel, Switzerland)|February 10, 2021
SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic StudiesMathias Boulanger, Mehuli Chakraborty, Denis Tempé, et al.
FEBS Letters|April 18, 2002
NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinasesGuillaume Bossis, Sara Salinas, Christine Cartier, et al.
Viruses|November 27, 2021
Regulation of Viral Restriction by Post-Translational ModificationsCélia Chamontin, Guillaume Bossis, Sébastien Nisole, et al.
Critical Reviews in Oncology/Hematology|March 23, 2005
Mechanisms of delivery of ubiquitylated proteins to the proteasome: new target for anti-cancer therapy?Rosa Farràs, Guillaume Bossis, Elisabetta Andermarcher, et al.
Molecular and Cellular Biology|October 1, 2003
c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivoGuillaume Bossis, Patrizia Ferrara, Claire Acquaviva, et al.
Biochimie|September 11, 2007
Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?Jihane Basbous, Isabelle Jariel-Encontre, Tiphanie Gomard, et al.
Medecine Sciences : M/S|February 5, 2005
[Proteasomal degradation: from addressing of substrates to therapeutical perspectives]Elisabetta Andermarcher, Guillaume Bossis, Rosa Farras, et al.
Methods in Enzymology|November 9, 2005
A fluorescence resonance energy transfer-based assay to study SUMO modification in solutionGuillaume Bossis, Katarzyna Chmielarska, Ulrike Gärtner, et al.
Biochemical Pharmacology|September 6, 2002
Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retrovirusesClaire Acquaviva, Guillaume Bossis, Patrizia Ferrara, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Cancers|October 10, 2020
DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic TargetsLudovic Gabellier, Caroline Bret, Guillaume Bossis, et al.
Molecules (Basel, Switzerland)|February 10, 2021
SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic StudiesMathias Boulanger, Mehuli Chakraborty, Denis Tempé, et al.
FEBS Letters|April 18, 2002
NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinasesGuillaume Bossis, Sara Salinas, Christine Cartier, et al.
Viruses|November 27, 2021
Regulation of Viral Restriction by Post-Translational ModificationsCélia Chamontin, Guillaume Bossis, Sébastien Nisole, et al.
Critical Reviews in Oncology/Hematology|March 23, 2005
Mechanisms of delivery of ubiquitylated proteins to the proteasome: new target for anti-cancer therapy?Rosa Farràs, Guillaume Bossis, Elisabetta Andermarcher, et al.
Molecular and Cellular Biology|October 1, 2003
c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivoGuillaume Bossis, Patrizia Ferrara, Claire Acquaviva, et al.
Biochimie|September 11, 2007
Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?Jihane Basbous, Isabelle Jariel-Encontre, Tiphanie Gomard, et al.
Medecine Sciences : M/S|February 5, 2005
[Proteasomal degradation: from addressing of substrates to therapeutical perspectives]Elisabetta Andermarcher, Guillaume Bossis, Rosa Farras, et al.
Methods in Enzymology|November 9, 2005
A fluorescence resonance energy transfer-based assay to study SUMO modification in solutionGuillaume Bossis, Katarzyna Chmielarska, Ulrike Gärtner, et al.
Biochemical Pharmacology|September 6, 2002
Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retrovirusesClaire Acquaviva, Guillaume Bossis, Patrizia Ferrara, et al.
Pageof 6